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Èlia Ripoll1, Laura de Ramon1, Juliana Draibe1, Ana Merino1, Nuria Bolaños1, Montse Goma2, Josep M. Cruzado1,
Josep M. Grinyó1 and Juan Torras1*Unfortunately, after publication of this article [1], it was
noticed that the name of Juliana Draibe was listed incor-
rectly. The corrected name can be seen in the author list
above and the original article has been updated to reflect
this change.
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